Patent · US Active

Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components

US8575123B2 · kind B2 · utility

52Cited by

4References

39Claims

0Family size

Assignee

Tekmira Pharmaceuticals Corporation · CA

Inventors

Muthiah Manoharan · Carlsbad, US
Kallanthottathil G. Rajeev · Wayland, US
David Butler · Medford, US
Muthusamy Jayaraman · Cambridge, US

Key dates

Filing date	Apr 10, 2009
Grant date	Nov 5, 2013
Priority date	—
Expiry date	Jul 29, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/32
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compositions and methods for site-specific delivery of nucleic acids by combining them with targeting ligands and endosomolytic components.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.